Advertisement

Clinical Drug Investigation

, Volume 39, Issue 1, pp 113–113 | Cite as

Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer

  • Griet HosteEmail author
  • Laurence Slembrouck
  • Lynn Jongen
  • Kevin Punie
  • Tom Matton
  • Sara Vander Borght
  • Isabelle Vanden Bempt
  • Johan Menten
  • Hans Wildiers
  • Giuseppe Floris
  • Carlos Arteaga
  • Patrick Neven
Correction
  • 330 Downloads

1 Correction to: Clinical Drug Investigation (2018) 38(11):1071–1075  https://doi.org/10.1007/s40261-018-0696-3

Conflict of interest, which previously read:

The authors declare that they have no competing interests.

Should read:

Dr. Arteaga serves on an Advisory Board for Novartis and was a consultant for AstraZeneca from 2015 to 2016. All other authors declare that they have no competing interests.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Griet Hoste
    • 1
    Email author
  • Laurence Slembrouck
    • 2
  • Lynn Jongen
    • 2
  • Kevin Punie
    • 2
    • 3
  • Tom Matton
    • 4
  • Sara Vander Borght
    • 5
    • 6
  • Isabelle Vanden Bempt
    • 6
  • Johan Menten
    • 1
    • 7
  • Hans Wildiers
    • 2
    • 3
  • Giuseppe Floris
    • 4
    • 8
  • Carlos Arteaga
    • 9
  • Patrick Neven
    • 1
    • 2
  1. 1.Department of Gynaecology and Obstetrics, University Hospitals LeuvenKU Leuven, University of LeuvenLouvainBelgium
  2. 2.Department of Oncology, University Hospitals LeuvenKU Leuven, University of LeuvenLouvainBelgium
  3. 3.Department of General Medical Oncology, University Hospitals LeuvenKU Leuven, University of LeuvenLouvainBelgium
  4. 4.Department of RadiologyKU Leuven, University Hospitals LeuvenLouvainBelgium
  5. 5.Department of PathologyKU Leuven, University Hospitals LeuvenLouvainBelgium
  6. 6.Department of Human Genetics, University Hospitals LeuvenKU Leuven, University of LeuvenLouvainBelgium
  7. 7.Department of Radiotherapy, University Hospitals LeuvenKU Leuven, University of LeuvenLouvainBelgium
  8. 8.Department of Imaging and Pathology, Laboratory of Translational Cell and Tissue ResearchKU Leuven, University of LeuvenLouvainBelgium
  9. 9.University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer CenterDallasUSA

Personalised recommendations